top of page
Jun 23, 2021
GIE Publishing Team
A balloon coated with the anticancer agent paclitaxel appears to hold significant promise for the treatment of patients with complicated esophageal stents.
A balloon coated with the anticancer agent paclitaxel appears to hold significant promise for the treatment of patients with complicated esophageal stents.
​
One year after dilatation with the experimental therapy, from GIE Medical, eight of nine patients with benign strictures have yet to experience a recurrence, researchers have found. Although the data are preliminary, experts said the findings, reported at the 2021 Digestive Disease Week (abstract 818), could herald a major advance in the management of esophageal narrowing.
bottom of page